ArticlePharmaceutics2020

Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant.

Fernanda P Pons-Faudoa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.